J Clin Aesthet Dermatol. 2020;13(9):15–20 by Andrea L. Zaenglein, MD; Jeanett Segal, MD; Charles Darby, MSc; and James Q. Del Rosso, DO Dr. Zaenglein is with Departments of Dermatology and Pediatrics at Penn State College of Medicine, Hershey Medical Center in Hershey, Pennsylvania. Dr. Segal is with Sun Pharmaceutical Industries, Inc., in Princeton, New Jersey.
J Clin Aesthet Dermatol. 2020;13(9):26–32 by Hilary Baldwin, MD Dr. Baldwin is the Medical Director of the Acne Treatment and Research Center in Brooklyn, New York and is with Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey. ABSTRACT: Acne vulgaris is the most common dermatological disease in the United States, affecting up
J Clin Aesthet Dermatol. 2020;13(9):21–23 by Ahmed A. Saleh, MD; Aiham M. Al-Obaidi, MSc; Eman G. Behiry, MD; and Ahmed Mohammed Hamed, MD Mr. Al-Obaidi, Dr. Saleh, and Dr. Hamed are with the Department of Dermatology and Andrology of the Faculty of Medicine at Benha University in Benha, Egypt. Dr. Behiry is with the Department
J Clin Aesthet Dermatol. 2020;13(9):49–51 by Gabriella Vasile, DO; Mojgan Hosseinipour, DO; Cindy Hoffman, DO; and Charles Gropper, MD Dr. Vasile is a resident at Larkin Community Hospital of Palm Springs Dermatology in Hialeah, Florida. Dr. Hosseinipour is a Dermatology resident at St. Barnabas Hospital in Bronx, New York. Dr. Gropper is a Dermatologist at
Dear Editor: We read the recent article, “Recurrence of Localized Pemphigus Foliaceus Induced by Knee Replacement,” with great interest.1 The authors attribute the presentation of unilateral pemphigus foliaceus (PF) in a previously uninvolved site to an immunocompromised district (ICD), where edema and nerve injury paved the way for a buildup of immunoglobulins and immune cells.